Show simple item record

dc.contributor.authorZhao, Sizheng
dc.contributor.authorYoshida, Kazuki
dc.contributor.authorJones, Gareth T
dc.contributor.authorHughes, David M
dc.contributor.authorTedeschi, Sara K
dc.contributor.authorLyu, Houchen
dc.contributor.authorMoots, Robert J
dc.contributor.authorSolomon, Daniel H
dc.contributor.authorGoodson, Nicola J
dc.date.accessioned2020-02-14T00:04:50Z
dc.date.available2020-02-14T00:04:50Z
dc.date.issued2020-04-01
dc.identifier.citationZhao , S , Yoshida , K , Jones , G T , Hughes , D M , Tedeschi , S K , Lyu , H , Moots , R J , Solomon , D H & Goodson , N J 2020 , ' Impact of Smoking in Response to Tumor Necrosis Factor Inhibitors in Axial Spondyloarthritis : Methodologic Considerations for Longitudinal Observational Studies ' , Arthritis Care & Research , vol. 72 , no. 4 , pp. 591-599 . https://doi.org/10.1002/acr.23851en
dc.identifier.issn0893-7524
dc.identifier.otherPURE: 142678063
dc.identifier.otherPURE UUID: 1c32a20c-4648-4591-b481-0030bc88ef46
dc.identifier.otherPubMed: 30762311
dc.identifier.otherMendeley: abc45b29-f7cf-3c87-8049-a597689e6a0b
dc.identifier.otherScopus: 85068977430
dc.identifier.otherWOS: 000521664600013
dc.identifier.otherORCID: /0000-0003-0016-7591/work/83703987
dc.identifier.urihttps://hdl.handle.net/2164/13693
dc.descriptionWe are grateful to Professor Gary Macfarlane (Chief Investigator of BSRBR-AS), the staff of the BSRBR-AS (Claudia Zabke, Elizabeth Ferguson-Jones, Maureen Heddle, Nafeesa Nazlee, and Barry Morris), and the recruiting staff at the clinical centers.en
dc.format.extent9
dc.language.isoeng
dc.relation.ispartofArthritis Care & Researchen
dc.rightsThis is the peer reviewed version of the following article: Zhao, S.S., Yoshida, K., Jones, G.T., Hughes, D.M., Tedeschi, S.K., Lyu, H., Moots, R.J., Solomon, D.H. and Goodson, N.J. (2020), Impact of Smoking in Response to Tumor Necrosis Factor Inhibitors in Axial Spondyloarthritis: Methodologic Considerations for Longitudinal Observational Studies. Arthritis Care Res, 72: 591-599., which has been published in final form at https://doi.org/10.1002/acr.23851. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.en
dc.subjectaxial spondyloarthritisen
dc.subjectankylosing spondylitisen
dc.subjectregistryen
dc.subjecttreatment responseen
dc.subjectinverse probability weightsen
dc.subjectR Medicineen
dc.subjectRheumatologyen
dc.subject.lccRen
dc.titleImpact of Smoking in Response to Tumor Necrosis Factor Inhibitors in Axial Spondyloarthritis : Methodologic Considerations for Longitudinal Observational Studiesen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Epidemiology Groupen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)en
dc.description.statusPeer revieweden
dc.description.versionPostprinten
dc.identifier.doihttps://doi.org/10.1002/acr.23851
dc.date.embargoedUntil2020-03-12
dc.identifier.urlhttp://www.mendeley.com/research/impact-smoking-response-tnf-inhibitors-axial-spondyloarthritis-methodological-considerations-longituen
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85068977430&partnerID=8YFLogxKen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record